Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. - Wikidata - wikimedia - TriplyDB

Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.

Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.

http://www.wikidata.org/entity/Q54404821

about

The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements Pattern Recognition Receptors in Cancer Progression and Metastasis Mucins and toll-like receptors: kith and kin in infection and cancer The Role of TLR4 in Chemotherapy-Driven Metastasis Tank binding kinase 1 is a centrosome-associated kinase necessary for microtubule dynamics and mitosis.Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy.Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo.Toll-like receptor 4 activation in cancer progression and therapy Decreased expression of Toll-like receptor 4 and 5 during progression of prostate transformation in transgenic adenocarcinoma of mouse prostate mice.TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer.TLR4 is a novel determinant of the response to paclitaxel in breast cancer TBK1 regulates prostate cancer dormancy through mTOR inhibition.Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers Toll-like receptors in prostate infection and cancer between bench and bedside Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling.Androgen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells.Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy.Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.Yin and yang of tumor inflammation: how innate immune suppressors shape the tumor microenvironments.Toll-like receptors and prostate cancer.Toll-like receptor 3 stimulation triggers metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF.Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells.Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.The dual role of TLR3 in metastatic cell line.High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.Inflammation and cancer.Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer TLR-10 polymorphism and papillary thyroid cancer: one more SNP to consider?Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast.Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis.Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis.Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy.Study of the expression of toll-like receptors in different histological types of colorectal polyps and their relationship with colorectal cancer.

P2860

Q26750672-7C703C42-0E41-4308-A48A-DD9F2FECF95B Q26798034-FBD89550-65BC-4E92-B421-295061EEE829 Q26830597-BFE814AD-D89D-4EAD-8600-F80F2715A443 Q26861495-D88CAAD0-A0D5-444F-8D24-F6C90AAB3B9C Q27342059-E7402BCF-48BC-4B18-8312-E85E86F18550 Q33586463-EDF01F92-8B26-41A1-BF19-6849F1002BC5 Q34290191-0D86D117-2030-484D-9802-2247A38AC69C Q34310501-FB0B893A-70A6-4303-AC23-22EB650AC7CC Q35235996-F5594539-4467-499F-AB83-E410B8E7DA6A Q35531400-DF1E49F5-1597-48B7-BD69-437381AE1A40 Q35550677-4DE1F5BD-BD88-423C-8C72-A5D4301B72B8 Q36105484-47B4120A-8666-46F7-BD97-6564BB111AC0 Q36232040-E8856E6A-C7F7-4257-B187-77C122BA41D2 Q36356021-1473B4F3-2C25-44A6-AF2F-25608151345A Q37093119-40BEA9B1-F677-4DFE-BB4E-4F08E330EB4A Q37162393-8CCA5347-3686-40DD-A3C8-0E82B1768DD9 Q37291780-DB2F6EBA-120A-4F29-A5CC-EBE61B4684D7 Q37295411-F71443FD-84D0-44B8-A6AA-853B47F2773E Q37437301-485F8661-1F83-43DD-80E7-DE054F6396BD Q37575463-22BD50E2-B5CA-43ED-AB16-2EAECAAADF07 Q37735619-45636EEC-8D0C-40CA-BD4C-A8F0F9B598A8 Q37952071-F0DFED43-CD4C-41D8-86B7-9AD9281BF0A7 Q37983730-5EAA616C-5C94-4246-BEC2-3F28E3494AEF Q38039958-E951E9EB-72E8-41BB-88A4-D3315A1128A2 Q38165824-BBB4EFBA-FC63-4317-BE31-0F1DAB3FE756 Q38237640-7FBB102A-3434-4432-B21F-3650CF2E7BF4 Q38734150-3418356A-E0EC-4FE1-B5F1-65B1AA9945C2 Q39339490-464DD228-E23F-4DB6-84FE-E50FA3C2679F Q39450716-76001287-7CEC-43A9-9AF3-E50958EC645F Q39511419-058A86C1-ECF3-47B8-B069-4DC66F6317D9 Q40338679-F9FB1BBC-08B2-47AE-A9E3-CFB6EA730D91 Q41853728-836D43C1-5D85-4A6D-BCF7-D53CF3B7E306 Q42149484-4865BC06-B09C-46AA-A4DC-8DAE8539FC6C Q43450367-0B82296D-4EC7-47D9-A040-302577AC1F2C Q44147242-017CAA00-6C0B-4C61-A097-FEBF7D3AF6E1 Q44484748-CE945DCF-99EF-4D30-81ED-07924291F8BD Q51872814-C2C1568C-17B7-4AAD-B47C-CEC11D2CBB02 Q52730051-E579290C-611C-4468-8D98-DA10145C4375 Q54112790-EBD308EC-5E00-4D82-A026-E306CD3CFB08 Q54321617-C0CBE867-1858-4829-B943-BFF879DB84A5

P2860

Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.

http://www.wikidata.org/entity/Q54404821

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Study of TLR3, TLR4, and TLR9 ...... n with biochemical recurrence.

@en

Study of TLR3, TLR4, and TLR9 ...... n with biochemical recurrence.

@nl

type

label

Study of TLR3, TLR4, and TLR9 ...... n with biochemical recurrence.

@en

Study of TLR3, TLR4, and TLR9 ...... n with biochemical recurrence.

@nl

prefLabel

Study of TLR3, TLR4, and TLR9 ...... n with biochemical recurrence.

@en

Study of TLR3, TLR4, and TLR9 ...... n with biochemical recurrence.

@nl

P1433

Q54404821-67E65827-BF2D-4B98-AD9E-3A086C21AAF7

P1476

Q54404821-26ED25F7-377F-45AC-A230-183FC41B93E0

P2093

Q54404821-3AA0F82E-3B91-4496-85AF-752FD8F2E73E

Q54404821-3BCDBE44-B733-4122-BD28-2EBBA67164F6

Q54404821-58F5E5BE-ACB8-488D-A93B-D5C75B32E00D

Q54404821-5E0CBEBD-8BA6-49B8-9362-3D15FAE70FD1

Q54404821-86270219-6F7F-4360-A114-88D54C782B39

Q54404821-9C657433-C3EB-48DE-A4B1-1E1B7E49D8F1

Q54404821-B71049E4-A56C-4A3B-B4E7-17695FDF936B

Q54404821-EB388B81-23DA-44A0-8D73-7711FEF922F7

P2860

Q54404821-013C72C0-D3BE-4257-B4F3-0E463B8179EE

Q54404821-18B49FD9-2091-4AD5-8A07-D3F4216D11E1

Q54404821-191A60B3-1E66-44FB-B3E6-B4E4302FF337

Q54404821-1A65558B-2E70-4A46-AEA7-69F01311C596

Q54404821-1CA48650-5F8E-411A-8673-27FCCA78DD8A

Q54404821-22F34763-E182-4770-83F3-6570D02272D4

Q54404821-28575882-B43A-45D6-AE73-5C73A34F6C9D

Q54404821-320E614D-8DDB-48AE-9CF0-F10C58350164

Q54404821-33A6E4FD-0F56-4B8A-A934-B1030A30A69F

Q54404821-34ACA388-1E46-4F34-9BC3-8CD7BD7FD717

P2888

Q54404821-E869DD81-2BD4-460A-AB05-D4C566CE8300

P304

Q54404821-15F71181-F7FB-48FA-A28A-B8EAD5986B4B

P31

Q54404821-B5CBB705-F8D4-4AD1-99DE-4F510D77F737

P356

Q54404821-CDA1D1FD-5CFC-4840-9D1F-593FDD698B9F

P433

Q54404821-BBDD4885-4BFD-4926-80C7-9AB40F4EFF25

P478

Q54404821-74BC7FDB-AB91-4C03-8FD5-0B1898CF1968

P577

Q54404821-C6E4F1A4-26D0-4913-A986-75121F0EEB62

P698

Q54404821-39439FC9-D700-47E0-B9DA-109A85EAC341

P921

Q54404821-0627D079-BAF6-4E29-9D5A-4E923FC4527E

P356

S00262-010-0931-0

P1433

Cancer Immunology, Immunotherapy

P1476

Study of TLR3, TLR4, and TLR9 ...... n with biochemical recurrence.

@en

P2093

Alina Aguirre

http://www.w3.org/2001/XMLSchema#string

Aurelio Suárez

http://www.w3.org/2001/XMLSchema#string

Francisco J Vizoso

http://www.w3.org/2001/XMLSchema#string

Jesús M Fernández

http://www.w3.org/2001/XMLSchema#string

José M González

http://www.w3.org/2001/XMLSchema#string

Luis O González

http://www.w3.org/2001/XMLSchema#string

Safwan Escaff

http://www.w3.org/2001/XMLSchema#string

Salomé González-Reyes

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer; a biological approach. I. The processes of control

Human lung cancer cells express functionally active Toll-like receptor 9

Paradoxical roles of the immune system during cancer development

Tumour-educated macrophages promote tumour progression and metastasis

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.

Study of matrix metalloproteinases and their inhibitors in prostate cancer.

Toll-like receptor signaling pathway variants and prostate cancer mortality.

P2888

s00262-010-0931-0

P304

217-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-010-0931-0

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20978888

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor